Literature DB >> 9311735

Spectrum of mutations in the Batten disease gene, CLN3.

P B Munroe1, H M Mitchison, A M O'Rawe, J W Anderson, R M Boustany, T J Lerner, P E Taschner, N de Vos, M H Breuning, R M Gardiner, S E Mole.   

Abstract

Batten disease (juvenile-onset neuronal ceroid lipofuscinosis [JNCL]) is an autosomal recessive condition characterized by accumulation of lipopigments (lipofuscin and ceroid) in neurons and other cell types. The Batten disease gene, CLN3, was recently isolated, and four disease-causing mutations were identified, including a 1.02-kb deletion that is present in the majority of patients (The International Batten Disease Consortium 1995). One hundred eighty-eight unrelated patients with JNCL were screened in this study to determine how many disease chromosomes carried the 1.02-kb deletion and how many carried other mutations in CLN3. One hundred thirty-nine patients (74%) were found to have the 1.02-kb deletion on both chromosomes, whereas 49 patients (41 heterozygous for the 1.02-kb deletion) had mutations other than the 1.02-kb deletion. SSCP analysis and direct sequencing were used to screen for new mutations in these individuals. Nineteen novel mutations were found: six missense mutations, five nonsense mutations, three small deletions, three small insertions, one intronic mutation, and one splice-site mutation. This report brings the total number of disease-associated mutations in CLN3 to 23. All patients homozygous for mutations predicted to give rise to truncated proteins were found to have classical JNCL. However, a proportion of the patients (n = 4) who were compound heterozygotes for a missense mutation and the 1.02-kb deletion were found to display an atypical phenotype that was dominated by visual failure rather than by severe neurodegeneration. All missense mutations were found to affect residues conserved between the human protein and homologues in diverse species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311735      PMCID: PMC1715900          DOI: 10.1086/514846

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Presidential address: Studies in the neuronal ceroid-lipofuscinoses.

Authors:  W Zeman
Journal:  J Neuropathol Exp Neurol       Date:  1974-01       Impact factor: 3.685

2.  Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16.

Authors:  M Gardiner; A Sandford; M Deadman; J Poulton; W Cookson; S Reeders; I Jokiaho; L Peltonen; H Eiberg; C Julier
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3.

Authors:  H M Mitchison; P B Munroe; A M O'Rawe; P E Taschner; N de Vos; G Kremmidiotis; I Lensink; A C Munk; K L D'Arigo; J W Anderson; T J Lerner; R K Moyzis; D F Callen; M H Breuning; N A Doggett; R M Gardiner; S E Mole
Journal:  Genomics       Date:  1997-03-01       Impact factor: 5.736

4.  Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients.

Authors:  M Dean; M B White; J Amos; B Gerrard; C Stewart; K T Khaw; M Leppert
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  Linkage disequilibrium between the juvenile neuronal ceroid lipofuscinosis gene and marker loci on chromosome 16p 12.1.

Authors:  T J Lerner; R M Boustany; K MacCormack; J Gleitsman; K Schlumpf; X O Breakefield; J F Gusella; J L Haines
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

6.  Localization of juvenile, but not late-infantile, neuronal ceroid lipofuscinosis on chromosome 16.

Authors:  W Yan; R M Boustany; C Konradi; L Ozelius; T Lerner; J A Trofatter; C Julier; X O Breakefield; J F Gusella; J L Haines
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

7.  Fine genetic mapping of the Batten disease locus (CLN3) by haplotype analysis and demonstration of allelic association with chromosome 16p microsatellite loci.

Authors:  H M Mitchison; A D Thompson; J C Mulley; H M Kozman; R I Richards; D F Callen; R L Stallings; N A Doggett; J Attwood; T R McKay
Journal:  Genomics       Date:  1993-05       Impact factor: 5.736

Review 8.  Neuronal ceroid-lipofuscinoses in childhood.

Authors:  P Santavuori
Journal:  Brain Dev       Date:  1988       Impact factor: 1.961

9.  Clinico-pathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities.

Authors:  K E Wisniewski; I Rapin; J Heaney-Kieras
Journal:  Am J Med Genet Suppl       Date:  1988

10.  Regional mapping of the Batten disease locus (CLN3) to human chromosome 16p12.

Authors:  D F Callen; E Baker; S Lane; J Nancarrow; A Thompson; S A Whitmore; D H MacLennan; R Berger; D Cherif; I Järvelä
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

View more
  57 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  [Juvenile neuronal ceroid lipofuscinosis. Ophthalmologic findings and differential diagnosis].

Authors:  T U Krohne; P Herrmann; J Kopitz; K Rüther; F G Holz
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  [Diagnostics and treatment of neuronal ceroid lipofuscinoses from the viewpoint of neuropediatricians].

Authors:  R Steinfeld
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

4.  Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells.

Authors:  Aija Kyttälä; Gudrun Ihrke; Jouni Vesa; Michael J Schell; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

5.  Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.

Authors:  Paul G Rothberg; Denia Ramirez-Montealegre; Sharon D Frazier; David A Pearce
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

Review 6.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

7.  Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients.

Authors:  María-Socorro Pérez-Poyato; Montserrat Milà Recansens; Isidre Ferrer Abizanda; Raquel Montero Sánchez; Laia Rodríguez-Revenga; Victoria Cusí Sánchez; M Mar García González; Rosario Domingo Jiménez; Rafael Camino León; Ramón Velázquez Fragua; Antonio Martínez-Bermejo; Mercè Pineda Marfà
Journal:  J Inherit Metab Dis       Date:  2011-04-16       Impact factor: 4.982

8.  Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  J M Kwon; H Adams; P G Rothberg; E F Augustine; F J Marshall; E A Deblieck; A Vierhile; C A Beck; N J Newhouse; J Cialone; E Levy; D Ramirez-Montealegre; L S Dure; K R Rose; J W Mink
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

9.  Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction.

Authors:  Ching-On Wong; Michela Palmieri; Jiaxing Li; Dmitry Akhmedov; Yufang Chao; Geoffrey T Broadhead; Michael X Zhu; Rebecca Berdeaux; Catherine A Collins; Marco Sardiello; Kartik Venkatachalam
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

10.  Nitric oxide signaling is disrupted in the yeast model for Batten disease.

Authors:  Nuno S Osório; Agostinho Carvalho; Agostinho J Almeida; Sérgio Padilla-Lopez; Cecília Leão; João Laranjinha; Paula Ludovico; David A Pearce; Fernando Rodrigues
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.